Merck’s HDL-Raising Cholesterol Combo Has “Formulation Issues”

MK-0524B Phase III studies remain on track, the company maintains.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet